Review: gonadotropins and development of ovarian cancer.
about
The detection, treatment, and biology of epithelial ovarian cancerRisk of ovarian cancer in women treated with ovarian stimulating drugs for infertilityAnimal models of ovarian cancerControlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysisCharacterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatmentReproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study.Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition.Fertility drug use and risk of ovarian tumors: a debated clinical challenge.Risk factors for ovarian cancer: an overview with emphasis on hormonal factors.E-cadherin expression and bromodeoxyuridine incorporation during development of ovarian inclusion cysts in age-matched breeder and incessantly ovulated CD-1 miceDysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence.Development of Follicle-Stimulating Hormone Receptor Binding Probes to Image Ovarian Xenografts.The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer.Evaluating the progenitor cells of ovarian cancer: analysis of current animal models.Follicle stimulating hormone modulates ovarian stem cells through alternately spliced receptor variant FSH-R3.Proliferation of the superficial epithelium of ovaries in senile female rats following oral administration of conjugated equine estrogens.In vivo evaluation of the genotoxic effects of gonadotropins on rat reticulocytes.Expression and purification of the extracellular domain of the human follicle-stimulating hormone receptor using Escherichia coli.Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology.GnRH analogues as an adjuvant therapy for ovarian cancer patients.Gonadotropins regulate N-cadherin-mediated human ovarian surface epithelial cell survival at both post-translational and transcriptional levels through a cyclic AMP/protein kinase A pathway.
P2860
Q21198791-BBD39F88-17E9-44FE-8A7A-B8FBD8B28E17Q24200437-075C5DCA-6DF1-4461-A11D-24BFC858328BQ24791470-D3C6A9CF-302D-4174-8FEF-82660ACECE74Q28281796-BDFE66DF-C17B-4BCF-B420-726CD802C6A1Q28537709-3E771E41-56C4-49F4-AFC7-EDC8C93E20A5Q34268606-57BD557A-357A-4D1A-93FC-028CBEDCED80Q34297011-CF7E781B-CCCC-46EE-BE62-A63D37EE00D2Q34297428-F83F1E34-13A5-4085-94FD-D88D2C4BEC91Q34764768-C86263C2-7E59-4029-AB6C-D232B7EFB313Q35757478-B7430E10-B8A1-4E79-9801-A8DE9FE5D48BQ36063538-407DA91F-9416-42F9-B57C-EBD4B6B1AEC1Q36462856-770A7CC5-9F36-49E9-B50F-4A943DCF0DCEQ36802249-A6FC41EE-AD96-4CF1-8CD7-E0DC8CC94289Q36916354-B230F947-8BDE-4C9E-9054-4F22D5B0EA8CQ37057192-A16881C1-B866-409F-A001-BE3406A3E64AQ37147427-E69C0554-9F64-4E81-A1E1-DDE88EFB6B38Q37639055-0844B3AF-AE9F-4590-90B4-61F593C2EA06Q44157086-0143208C-BB8E-4FCB-80DB-A3E3E2C1B995Q44188023-C7F0119D-0201-443A-991A-1893DB778530Q44410553-81BFB9B0-811E-4954-93D2-3B64F486FDB1Q45258101-8B96122E-134A-4C84-9D5B-0E62793581DF
P2860
Review: gonadotropins and development of ovarian cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Review: gonadotropins and development of ovarian cancer.
@ast
Review: gonadotropins and development of ovarian cancer.
@en
type
label
Review: gonadotropins and development of ovarian cancer.
@ast
Review: gonadotropins and development of ovarian cancer.
@en
prefLabel
Review: gonadotropins and development of ovarian cancer.
@ast
Review: gonadotropins and development of ovarian cancer.
@en
P2093
P356
P1433
P1476
Review: gonadotropins and development of ovarian cancer.
@en
P2093
P356
10.1159/000055274
P478
57 Suppl 2
P577
1999-10-01T00:00:00Z